Combined
androgen blockade is abbreviated as CAB
and is a type of prostate cancer hormone therapy which
combines an anti-androgen with either chemical castration
or surgical castration. 90 to 95 percent testosterone
is produced by the testicles while 5 to 10 percent is
produced by the adrenal glands. Combined androgen blockade
ablates 100 percent of the testosterone present in the
blood stream. Combined androgen blockade is also known
as total androgen blockade and combined hormone blockade.
|
